Showing results (1531-1540 of 2,791) with videos related to

Sort By:
Pageof 280
Cytotherapy|April 8, 2010
Genetic manipulation of murine embryonic stem cells with enhanced green fluorescence protein and sulfatase-modifying factor I genesGuoying Zhao, Litsa Karageorgos, Rhonda G Hutchinson, et al.
Cytotherapy|June 6, 2009
Combined bone marrow and peripheral blood progenitor cell autografts for patients with poor mobilizationYelena Sinitsyn, Adriana Malone, John Mandeli, et al.
Cytotherapy|June 16, 2009
The role of placental-derived adherent stromal cell (PLX-PAD) in the treatment of critical limb ischemiaWilliam R Prather, Amir Toren, Moran Meiron, et al.
Cytotherapy|June 17, 2009
Longitudinal immune monitoring of patients receiving intratumoral injection of a MART-1 T-cell receptor-transduced cell line (C-Cure 709)Tania Køllgaard, Lone Duval, Henrik Schmidt, et al.
Cytotherapy|September 15, 2009
Nuclei-size distributions as predictive tools of hematopoietic cell proliferationP C Collins, S D Patel, E T Papoutsakis, et al.
Cytotherapy|September 15, 2009
Development of an infusible-grade solution for non-cryopreserved hematopoietic cell storageS R Burger, A Hubel, J McCullough
Cytotherapy|September 15, 2009
Improvement of breast cancer cell detection by immunomagnetic enrichmentW Krüger, F Tögel, S Rössing, et al.
Cytotherapy|September 15, 2009
The CD34+ cell concentration in peripheral blood predicts CD34+ cell yield in the leukapheresis productK L Hollingsworth, T M Zimmerman, T Karrison, et al.
Cytotherapy|September 15, 2009
Selection of CD34+ cells from cryopreserved PBPC can be significantly improved by the addition of recombinant human DNase (Pulmozyme)M J Alcorn, L J Richmond, E Farrell, et al.
Cytotherapy|May 2, 2021
Bone marrow toxicity and immune reconstitution in melanoma and non-melanoma solid cancer patients after non-myeloablative conditioning with chemotherapy and checkpoint inhibitionAnders H Kverneland, Troels Holz Borch, Joachim Granhøj, et al.
Pageof 280